TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 1 | 0 | 7 | 9 | 10 | 57 | 14 |
| P | %wins | 50 | 50 | 100 | 75 | 25 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/07 18:35 | 3/1/07 | ABAX | Abaxis Inc | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Milder Robert | CA | O | Chief Op | P.d | 29 | 1.95 | 6 | 15 | 146 | 25 | D | 105 | 3 | -5 | 15 | 22 | 4 | -4 | -6 | -4 | 0 | 9 | 2 | -13 | 30 |
2/22/07 19:05 | 2/20/07 | ABAX | Abaxis Inc | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Milder Robert | CA | O | Chief Op | P.d | 68 | 2.27 | 7 | 30 | 25 | D | 79 | 11 | 1 | 16 | 23 | 9 | 10 | 4 | 2 | -2 | 6 | -5 | -11 | 19 | |
2/7/07 18:34 | 2/6/07 | ABAX | Abaxis Inc | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Milder Robert | CA | O | Chief Op | P.d | 35 | 2.34 | 6 | 15 | 146 | 25 | D | 76 | 14 | -2 | 18 | 20 | 19 | 10 | 4 | -2 | -4 | 0 | 2 | -13 | 20 |
5/3/05 20:32 | 5/2/05 | ABAX | Abaxis Inc | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Milder Robert | CA | O | Chief Op | P | 47 | 9.34 | 1 | 5 | 12 | 48 | D | 112 | -47 | -27 | -31 | 3 | 9 | 22 | 22 | 6 | 7 | 12 | 38 | 77 | 159 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |